On Thursday shares of ArQule Inc. (NASDAQ:ARQL) closed at $1.86. Company’s sales growth for last 5 years was -14.80% and EPS growth for next 5 years is recorded as 5.00%. ArQule, Inc. (NASDAQ:ARQL) and Beryllium Discovery Corp. announced a collaborative research and development agreement to identify and unlock the therapeutic potential of small molecule compounds by combining ArQule’s chemistry and drug development expertise with Beryllium’s discovery platforms. The Beryllium platforms integrate structure-guided drug discovery, biophysics and cell biology.
ImmuCell Corp. (NASDAQ:ICCC) in last trading activity fell -1.47% to close at $5.72. Company weekly performance is -10.28% while its quarterly performance stands at -5.07%. ImmuCell Corp. (NASDAQ:ICCC) is -20.84% away from its 52 week high. ImmuCell Corporation (NASDAQ:ICCC) will report first quarter of 2015 financial results after the market closes on Tuesday, May 12, 2015. The Company has scheduled a conference call that same day Tuesday, May 12, 2015, at 4:30 PM EDT to review the results.
On last trading day Cascade Microtech Inc. (NASDAQ:CSCD) advanced 0.35% to close at $14.25. Its volatility for the week is 2.03% while volatility for the month is 2.33%. CSCD’s sales growth for past 5 years was 21.50% and its EPS growth for past 5 years was 27.30%. Cascade Microtech Inc. (NASDAQ:CSCD) monthly performance is 2.37%. On Apr 29, Cascade Microtech Inc. (NASDAQ:CSCD) reported financial results for the first quarter ended March 31, 2015. Total revenue of the company is reported as $31.7 million, compared to $36.6 million for Q4 2014 and $33.7 million for Q1 2014.
Lake Shore Gold Corp. (NYSEMKT:LSG) on last trading activity company’s stock closed at $1.05. Lake Shore Gold Corp. (NYSEMKT:LSG) announce that all matters presented for approval at the Company’s annual general meeting of shareholders held on April 29, 2015, were duly authorized and approved, as follows: setting the number of directors at eight and election of Lake Shore Gold’s nominees to the board of directors of the Company; and appointment of Deloitte LLP as auditors of the Company for the ensuing year and authorization of the directors to fix their remuneration.
On last trading day Gaiam Inc. (NASDAQ:GAIA) fell -0.15% to close at $6.72. Its volatility for the week is 4.55% while volatility for the month is 4.47%. GAIA’s sales growth for past 5 years was -9.80% and its EPS growth for past 5 years was 152.26%. Gaiam Inc. (NASDAQ:GAIA) monthly performance is -6.93%. GAIAM, Inc. (NASDAQ:GAIA), reported financial results for the first quarter ended March 31, 2015. First Quarter 2015 Financial Results Net revenue in the first quarter of 2015 was comparable to last year at $37.6 million. GAIAM Brand net revenue in the first quarter decreased 2% to $34.5 million compared to the same year-ago quarter. Excluding planned declines in catalog sales, GAIAM Brand net revenue in the first quarter of 2015 increased 4% to $32.3 million.